[Fk4-info] Putting anal cancer screening into practice [Session Highlight ]

[EUROGIN 2024]

Final discount rates closing soon! Register now! Stockholm, March 13-16, 2024

Click here to view it online (
http://tracking.eurogin.org/tracking/click?d=aBGCum0EJB32AMc6EHIsFNfeZlkJYrWKKxrW4Ql7_NwGdNXwS9uBmB8Y7X1EQETwrI1EGlyq8xvCRNiCzHjztn9nOpUbflH3pug2pqgXZvSX9j8iJJCwc7q4v3EOPAZcBabxtRX4JS64fTS5wkXQMB6E56CoCubxdFh1xJ5gn7LCJXZMacKJDNepLPwmLhSRGaFKnKF_EXp_8VLJ1wvw2B7tRd7FgTEJaPoGLMrpgxBICwqk9K7WJYDl8yNjyEE-d5iWrRcbFCs-MPPdX26R6yRqbG868zbjvprH7Hhjbpqiafit8ZrpAy1yDGk9PBebACiRX485uhY3gruVRp8dPYs1
)

INTERNATIONAL MULTIDISCIPLINARY HPV CONGRESS

MARCH 13-16, 2024
Waterfront Congress Centre
Stockholm, Sweden

▼ SAVE UP TO €110 ON YOUR PASS ( http://tracking.eurogin.org/tracking/click?d=Tocs-WJK9GGomxenPdUIuwLYIWVZqqllis4ZyZz8vyW7bz9vuKnSe4laGqI9hUV4LyhRilXb7hM9NFFyfWu_UF39lrwpBzL2L8j6n0CmhHgx0Yn1-kOPb8AiuNYzKh4opyq8KTnt_8jVtzvtaX7KPW4GoSLl52F_LBDuL1Ojkdak0N4XrjuAWgkMMLBlLXnPTBH9FQPrrXuGaYw4a-NQmbzDBHjVDxNcmpoE6VrYBKhlbLVrMWyCrXzgXQwSoJN6RA2
)

Session Highlight
Putting anal cancer screening into practice:
Implementation science, biomarker development, and self-sampling

The development of successful anal cancer screening programs is dependent upon the discovery of efficient biomarkers that identify persons at highest
risk for disease. But it is also dependent upon the delivery of screening programs that are acceptable to health care providers and communities at
increased risk for anal cancer. This session will address the intersection of biomarker development and implementation research for anal cancer
screening and the potential impact on screening uptake.

Session Details
Wednesday, March 13
15:30 - 17:00

What is the epidemiology of anal cancer with a focus on disparities by HIV, race, and sexual orientation?

A. Deshmukh
(USA)

What is implementation research in the context of anal cancer screening?

A. Burchell
(Canada)

What is the current state of biomarker development for anal cancer screening?

M. Clarke
(USA)

How might siloed biomarker development impact engagement with anal cancer screening?

A. Nyitray
(USA)

Anal cancer screening among women with HIV: Provider and patient perspectives

R. Higashi
(USA)

REFERENCES:

Home-based self-sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self-Swab Study (
http://tracking.eurogin.org/tracking/click?d=X10ecbZeekAGFQEmxaNnvUeblBhlT475SM2TtXJAqr_GYE-1MN72Bx07plqt_GQ1v5jkimylFp5yMjTA4eonnC8NpgehcdjT7RZKUHzmrokgrq8ChML29RV5JMxWfWQvRVMeswB5YsEoA-4d2ZL5iYvr-6gMWwQ1an2WUaROA0s2T17aAKvp-cHDPtbJ-aNogI3gpDU-ZS2AqonxLLYzBoTsuhCjLdffPJllu_HuEDdikd-n-w3gAKfmf7mH62RHKA2 )
Nyitray AG, Nitkowski J, McAuliffe TL, Brzezinski B, Swartz MD, Fernandez ME, Deshmukh AA, Ridolfi TJ, Lundeen SJ, Cockerham L, Wenten D, Petroll A,
Hilgeman B, Smith JS, Chiao EY, Giuliano AR, Schick V, Prevent Anal Cancer Self-Swab Study T. Home-based self-sampling vs clinician sampling for anal
precancer screening: The Prevent Anal Cancer Self-Swab Study. Int J Cancer. 2023;153(4):843-53. Epub 20230509. doi: 10.1002/ijc.34553. PubMed PMID:
37158105; PMCID: PMC10330574.

Influence of previous experience with and beliefs regarding anal cancer screening on willingness to be screened among men living with HIV (
http://tracking.eurogin.org/tracking/click?d=X10ecbZeekAGFQEmxaNnvUeblBhlT475SM2TtXJAqr_GYE-1MN72Bx07plqt_GQ1v5jkimylFp5yMjTA4eonnC8NpgehcdjT7RZKUHzmrontBCDUFcl1HiarI3vtwW2rYKuJaTFH4LQ54nq2SA9AIRCEVZio2xMEJs_yPa5oSko_3TjNfEVSz6JVS7noF_fNBAOlc5C1tLU7nSp3L0blvBUipeiuKbdjT9dy-nJzgtzCRbkb9s6kQOimBX0o-bdCVw2 )
Gillis JL, Grennan T, Grewal R, Ogilvie G, Gaspar M, Grace D, Lofters A, Raboud JM, Saarela O, MacPherson P, Rosenes R, Salit IE, Burchell AN; OHTN
Cohort Study Team. Influence of previous experience with and beliefs regarding anal cancer screening on willingness to be screened among men living
with HIV. BMC Public Health. 2022 Dec 28;22(1):2444. doi: 10.1186/s12889-022-14471-4. PMID: 36577960; PMCID: PMC9795733.

A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups (
http://tracking.eurogin.org/tracking/click?d=X10ecbZeekAGFQEmxaNnvUeblBhlT475SM2TtXJAqr_GYE-1MN72Bx07plqt_GQ1v5jkimylFp5yMjTA4eonnC8NpgehcdjT7RZKUHzmromXCnb61rymb0iUIulffxwDYFcnxYoqT9PYlipPno9Sxwkh4D6a-tQFC6GLxtZs2c3GuFAhzz--TAOCLiQQUy6XlrTvtKHIqw0smdHQOeRYRbOwueyYg0RZFuuvDyzA57xdEZXDdbtq4SMIC-NdpiAkQg2 )
Clarke MA, Deshmukh AA, Suk R, Roberts J, Gilson R, Jay N, Stier EA, Wentzensen N. A systematic review and meta-analysis of cytology and HPV-related
biomarkers for anal cancer screening among different risk groups. Int J Cancer. 2022 Dec 1;151(11):1889-1901. doi: 10.1002/ijc.34199. Epub 2022 Aug 6.
Erratum in: Int J Cancer. 2023 Sep 1;153(5):E2. PMID: 35793241; PMCID: PMC9588562.

REGISTER NOW ( http://tracking.eurogin.org/tracking/click?d=X10ecbZeekAGFQEmxaNnvUeblBhlT475SM2TtXJAqr_GYE-1MN72Bx07plqt_GQ1v5jkimylFp5yMjTA4eonnC8NpgehcdjT7RZKUHzmronl_9qZpFLPiF3ATUkHZ13WaaA0SGNWWj9binylozFNe6B1YnriGvFx9LCOGntLGBFovPuWTqkCfLLhc8-VIQp9LiUFaTc7YXcI6q8qs3ZE4LC4NAI4gQ8S6KvKJ9CSEHqqKUTTpHffM3QqtpduIsePrQ2 )

DISCOVER PROGRAM ( http://tracking.eurogin.org/tracking/click?d=Tocs-WJK9GGomxenPdUIuwLYIWVZqqllis4ZyZz8vyW7bz9vuKnSe4laGqI9hUV4LyhRilXb7hM9NFFyfWu_UF39lrwpBzL2L8j6n0CmhHiA1_uTipmjRyTR2iPP6s4Gx3oTqOu1QDOQB2Gh77TZGsgU152yjkrfDDG0cwRcu--51xnSSedH7IHwThZaOfhorx972mpaJN81xh8TOZYKHzbvmeIloij6fmEj0V38aM0O1EimXB3Z2LlXMGnz5h4Xxg2 )

Save up to €110 if you register before February 12
with the Early Bird Rates.

Exclusive hotel rates for
EUROGIN 2024 in Stockholm

To make your stay as convenient as possible, we've reserved rooms in close proximity to our Stockholm venue, offering competitive rates exclusively
for EUROGIN attendees.

BOOK YOUR HOTEL ( http://tracking.eurogin.org/tracking/click?d=Tocs-WJK9GGomxenPdUIuwLYIWVZqqllis4ZyZz8vyW7bz9vuKnSe4laGqI9hUV4LyhRilXb7hM9NFFyfWu_UF39lrwpBzL2L8j6n0CmhHhwM4uIrZNV4dz5WZRtpFL7w_v7xGWVrwYaXSF7Dg5Mhv_LN2TRHVxVxynoiiDjPDk8xRTh0BfW9ze6hVIkgYxxBEiswi-MZzGwCluknmkVAe6dVJCM5GBy0Ck3VOEYon6gVsdKaHCXHhEAzRNS9DDYDw2 )

The EUROGIN Organizing Team looks forward to welcoming you to EUROGIN 2024 in Stockholm!
 
Kindest regards,
The EUROGIN team

Registration Information ( http://tracking.eurogin.org/tracking/click?d=Tocs-WJK9GGomxenPdUIuwLYIWVZqqllis4ZyZz8vyW7bz9vuKnSe4laGqI9hUV4LyhRilXb7hM9NFFyfWu_UF39lrwpBzL2L8j6n0CmhHja47SQDQjJZzyQgY42PuNH5lL6N3D40XixVcr5GCPyicrBsg3XL3laDlnJu-FFspNJpCALnDxLDCpX1JbqtimviE1KlGIhzZgUo1T8Fm-kdrVO5-ltJ7pxWZ8U5LOeKY0mFQv9Xpa_PPg0phrylwM2xQ2 )

Sponsorship Brochure ( http://tracking.eurogin.org/tracking/click?d=Tocs-WJK9GGomxenPdUIuwLYIWVZqqllis4ZyZz8vyW7bz9vuKnSe4laGqI9hUV4LyhRilXb7hM9NFFyfWu_UF39lrwpBzL2L8j6n0CmhHg-yyNlzPM5455YAoxUPp0EHbXNLl7tr4SOrxcMGPHPKABzC-TaJ7tub_HAJe_WzCW6_V-fyRbqKWdS6QSdXr6gncngqAFsRQ9kSFFyMytdn24YWwPgIlOr74-2jEjVbK4dKsVoz2fOyB-dsFqZp728rQ2 )

Contact Us ( http://tracking.eurogin.org/tracking/click?d=Tocs-WJK9GGomxenPdUIuwLYIWVZqqllis4ZyZz8vyW7bz9vuKnSe4laGqI9hUV4LyhRilXb7hM9NFFyfWu_UF39lrwpBzL2L8j6n0CmhHjZd-fl-PRg5FbtG5ERN8H6F7-SiIiG12UpcxIHsvOfWpciLAWIHf86LSP6rPhCMYnvG7rmigBGQ4pKBePIisX3W3A7eC6tWwQaVM2eIBMibk47KaLHLerWY1uJ_FQ52CILdroaXMziSFoRaHnwhyMyiQ2 )

2023 Post Meeting Report ( http://tracking.eurogin.org/tracking/click?d=Tocs-WJK9GGomxenPdUIuwLYIWVZqqllis4ZyZz8vyW7bz9vuKnSe4laGqI9hUV4LyhRilXb7hM9NFFyfWu_UF39lrwpBzL2L8j6n0CmhHi4DX_QU61N_lMVrN61pYCh4mO8EqdX1h94m7gZEcK2Osz2oCbRj1s3rZh0cs3qho0i43Ogbi_-779ffGEHjb-8xTQmtmUeXlRQlAmEbKO-2c-dqnsKT6Tyyna6XWduDJ20n6HyZtmpkuwRV01ZHyau9w2 )

MORE INFORMATION ON
WWW.EUROGIN.COM ( http://tracking.eurogin.org/tracking/click?d=X10ecbZeekAGFQEmxaNnvUeblBhlT475SM2TtXJAqr_GYE-1MN72Bx07plqt_GQ1v5jkimylFp5yMjTA4eonnC8NpgehcdjT7RZKUHzmromI36VOrN9b9dqWtq3ZnoxCEStGFQBy4NCvXj9Xcs9Ztr9io0SqvHqEPXJ8uGfFoMKc239XY5aUy9YqAeg_HDTVaTbQjnSWSxRODgyGTyXPq9kvQ_Fx2IqOuvf8MaHwYrRcdWbGWIrfDN9QJtB8mVLY3Q2 )
admin at eurogin.com ( mailto:admin at eurogin.com )

Unsubscribe ( http://tracking.eurogin.org/tracking/click?d=dgdNn3WnwQ5o5kfTEgksPoH_rpRkEHwdunjd9JjaZxIqSBGC-1D7Gg30nHE3ceCQjiwGJ85ihZbUdovnM_81voYD2rsEUWDzl9im69q9WrgquqOsm5YRELEzLbSWNlGLInhM_r5H7Ao_tIVl3q8M8Py6gAUbgx4MbuvQB1Wk5r7ULIRtjfd1BtLYrS4HppE8UWSSezMbceOKNoMCb9KXJJwiSNzXUey50N5M_lckUeSaKVKNeAJoHyQ6RT76TtTV_vgUNKgYPwA-wHi9SG0UuWQ1 )

EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia), 174, rue de Courcelles, Paris, Île-de-France, 75017, France, http://tracking.eurogin.org/tracking/click?d=capLFI4mcp1Ex8830pa4oQj6cn8S9COs-i0iUvcXgOJu5_A9YIo-FIB3wbUtVUoORFi_48f9JTiXW0RQR1LdvRzA3gQO7yvecdu_J36m7W2B7DRqc3lf66r1YapVoWPgEYRYlh1IZ-vsiW7jc7_dr1U1
http://tracking.eurogin.org/tracking/unsubscribe?d=MM895JQ0wxZ_LXFFc1cwUM8eh0AQy_7_cdMHrgukAU3__6mRYwW4RxBgJ2_Sf9f3-O28K2R8yy6K05uW1YlSJqzflvIQoNfZOG8ajAQYhiZE0
-------------- nächster Teil --------------
Ein Dateianhang mit HTML-Daten wurde abgetrennt...
URL: <http://lists.uni-wuppertal.de/pipermail/fk4-info/attachments/20240203/d1a5e2d9/attachment-0001.html>